难治性糖尿病黄斑水肿危险因素的研究进展  

Research progress on risk factors of refractory diabetic macular edema

作　　者：许诚豪 杨帆[1] 游志鹏[1] XU Chenghao;YANG Fan;YOU Zhipeng(The Affliated Eye Hospital of Nanchang University,Jiangxi Eye Hospital,Key Laboratory of Vitreoretinal Diseases of Jiangxi Health,Nanchang 330006,Jiangxi Province,China)

机构地区：[1]南昌大学附属眼科医院、江西省眼科医院、江西省卫生健康玻璃体视网膜疾病重点实验室,江西省南昌市330006

出　　处：《眼科新进展》2024年第9期744-748,共5页Recent Advances in Ophthalmology

基　　金：江西省科技厅重点研发计划重点项目(编号:20223 BBH80W01);江西省卫建委科技创新重点项目(编号:2023ZD004)。

摘　　要：糖尿病黄斑水肿(DME)是糖尿病视网膜病变中最常见的引起视力下降的并发症。DME的发病机制复杂,约1/3的DME患者对抗血管内皮生长因子药物应答不佳,我们将其定义为难治性DME。对难治性DME的危险因素的早期识别十分重要,有助于判断患者的预后,并指导临床治疗。本文对难治性DME的危险因素进行综述。Diabetic macular edema(DME)is the most common complication of diabetic retinopathy,which can cause vision loss in patients.The nosogenesis of DME is complicated,and about 1/3 DME patients have poor response to anti-vascular endothelial growth factor therapy,which is defined as refractory DME.The early identification of the risk factors of refractory DME is crucial and helpful for doctors to predict the prognosis of DME and guide clinical treatment.This article reviews the risk factors of refractory DME.

关 键 词：难治性糖尿病黄斑水肿 抗血管内皮生长因子 危险因素 

分 类 号：R774.5[医药卫生—眼科]